The Risk of Metachronous Advanced Neoplasia After Colonoscopy in Patients Aged 40-49 Years Compared With That in Patients Aged 50-59 Years.
Journal
The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
received:
05
04
2022
accepted:
29
07
2022
pubmed:
17
8
2022
medline:
10
1
2023
entrez:
16
8
2022
Statut:
ppublish
Résumé
This study investigated the risk of metachronous advanced neoplasia (AN) after colonoscopy in individuals aged 40-49 years compared with that in individuals aged 50-59 years. A retrospective cohort study was performed among Kaiser Permanente Northern California members aged 40-59 years who had their first (index) colonoscopy in 2010-2013. Participants were followed up until death, disenrollment, AN on surveillance colonoscopy, or December 31, 2018. The risk for the development of AN was estimated using the Cox regression, adjusted for confounders. The study included 11,374 patients (2,396 aged 40-49 years and 8,978 aged 50-59 years). When comparing the 40-49 years group with the 50-59 years group, AN was detected in 2.2% vs 4.4% ( P = 0.0003) on surveillance colonoscopy after index colonoscopy finding of no adenoma, in 4.6% vs 7.0% ( P = 0.03) after a finding of nonadvanced adenoma (NAA), and in 7.9% vs 11.7% ( P = 0.06) after a finding of advanced adenoma (AA), respectively. Compared with the 50-59 years group, the 40-49 years group had a lower risk of metachronous AN when no adenoma was detected on index colonoscopy (hazard ratio [HR] 0.58; 95% confidence interval [CI] 0.39-0.83) and no difference when NAA (HR 0.84; 95% CI 0.54-1.24) or AA (HR 0.83; 95% CI 0.51-1.31) was detected. Compared with patients aged 50-59 years, patients aged 40-49 years may have a lower risk of developing metachronous AN when no adenoma is detected on index colonoscopy and a similar risk when NAA or AA is detected. These data suggest current surveillance colonoscopy guidelines may be applicable to patients aged 40-49 years who undergo colonoscopy.
Identifiants
pubmed: 35971223
doi: 10.14309/ajg.0000000000001946
pii: 00000434-202301000-00026
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148-156Informations de copyright
Copyright © 2022 by The American College of Gastroenterology.
Références
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7–34.
Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116(3):544–73.
Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst 2017;109(8):djw322.
Meester RGS, Mannalithara A, Lansdorp-Vogelaar I, et al. Trends in incidence and stage at diagnosis of colorectal cancer in adults aged 40 through 49 years, 1975–2015. JAMA 2019;321(19):1933–4.
Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 2015;150(1):17–22.
US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Share screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2021;325(19):1965–77.
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68(4):250–81.
Patel SG, May FP, Anderson JC, et al. Updates on age to start and stop colorectal cancer screening: Recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2022;117(1):57–69.
Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143(3):844–57.
Gupta S, Lieberman D, Anderson JC, et al. Share recommendations for follow-up after colonoscopy and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2020;158(4):1131–53.
Park SK, Kim NH, Jung YS, et al. Risk of developing advanced colorectal neoplasia after removing high-risk adenoma detected at index colonoscopy in young patients: A KASID study. J Gastroenterol Hepatol 2016;31(1):138–44.
Yamaji Y, Mitsushima T, Yoshida H, et al. The malignant potential of freshly developed colorectal polyps according to age. Cancer Epidemiol Biomarkers Prev 2006;15(12):2418–21.
Kim NH, Jung YS, Park JH, et al. Risk of developing metachronous advanced colorectal neoplasia after colonoscopic polypectomy in patients aged 30 to 39 and 40 to 49 years. Gastrointest Endosc 2018;88(4):715–23.
Kim NH, Jung YS, Park JH, et al. Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged <50 years. J Gastroenterol Hepatol 2019;34(2):383–9.
Kim HG, Cho YS, Cha JM, et al. Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia. Gastrointest Endosc 2018;87(3):666–73.
Anderson JC, Robinson CM, Butterly LF. Young adults and metachronous neoplasia: Risks for future advanced adenomas and large serrated polyps compared with older adults. Gastrointest Endosc 2020;91(3):669–75.
Gordon NP. Similarity of the Adult Kaiser Permanente membership in Northern California to the insured and general population in Northern California: Statistics from the 2011 California Health Interview Survey. 2015.
Fevrier HB, Liu L, Herrinton LJ, et al. A transparent and adaptable method to extract colonoscopy and pathology data using natural language processing. J Med Syst 2020;44(9):151.
Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and deaths. N Engl J Med 2014;370(14):1298–306.
Montminy EM, Zhou M, Maniscalco L, et al. Share contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates in the United States. Ann Intern Med 2021;174(2):157–66.
Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369(12):1095–105.
Samadder NJ, Pappas L, Boucherr KM, et al. Long-term colorectal cancer incidence after negative colonoscopy in the state of Utah: The effect of family history. Am J Gastroenterol 2017;112(9):1439–47.
Lee JK, Jensen CD, Levin TR, et al. Long-term risk of colorectal cancer and related deaths after a colonoscopy with normal findings. JAMA Intern Med 2019;179(2):153–60.
Hassan C, Gimeno-García A, Kalager M, et al. Systematic review with meta-analysis: The incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas. Aliment Pharmacol Ther 2014;39(9):905–12.
Dubé C, Yakubu M, McCurdy BR, et al. Share risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: A systematic review and meta-analysis. Am J Gastroenterol 2017;112(12):1790–801.
Fairley KJ, Li J, Komar M, et al. Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol 2014;5(12):e64.
Good NM, Macrae FA, Young GP, et al. Ideal colonoscopic surveillance intervals to reduce incidence of advanced adenoma and colorectal cancer. J Gastroenterol Hepatol 2015;30(7):1147–54.
van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, et al. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology 2013;144(7):1410–8.
Sneh Arbib O, Zemser V, Leibovici Weissman Y, et al. Risk of advanced lesions at the first follow-up colonoscopy after polypectomy of diminutive versus small adenomatous polyps of low-grade dysplasia. Gastrointest Endosc 2017;86(4):713–21.
Vemulapalli KC, Rex DK. Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: Data from a single U.S. center. Gastrointest Endosc 2014;80(2):299–306.
Enwerem N, Cho MY, Demb J, et al. Systematic review of prevalence, risk factors, and risk for metachronous advanced neoplasia in patients with young-onset colorectal adenoma. Clin Gastroenterol Hepatol 2021;19(4):680–9.e12.
Butterly LF, Siegel RL, Fedewa S, et al. Colonoscopy outcomes in average-risk screening equivalent young adults: Data from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 2021;116(1):171–9.
Yen T, Scolaro J, Montminy E, et al. Spectrum of advanced colorectal neoplasia and anticipated yield of average-risk screening in veterans under age 50. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01229-5.
Cha JM, La Selva D, Kozarek RA, et al. Young patients with sporadic colorectal adenomas: Current endoscopic surveillance practices and outcomes. Gastrointest Endosc 2018;88(5):818–25.
Song M, Emilsson L, Hultcrantz R, et al. Long-term incidence and mortality of colorectal cancer after endoscopic biopsy with normal mucosa: A Swedish-matched cohort study. Am J Gastroenterol 2021;116(2):382–90.
Pilonis ND, Bugajski M, Wieszczy P, et al. Share long-term colorectal cancer incidence and mortality after a single negative screening colonoscopy. Ann Intern Med 2020;173(2):81–91.
Li D, Doherty AR, Raju M, et al. Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps. Gut 2021:gutjnl-2021-324301.
Li D, Liu L, Fevrier HB, et al. Increased risk of colorectal cancer in individuals with a history of serrated polyps. Gastroenterology 2020;159(2):502–11.
Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2020;115(3):415–34.